Daniel Schneeberger: Stock Portfolio, Performance and Latest Trades
ADAR1 Capital Management
13F portfolio value
$2.2B
277 holdings at Q2 2026
Get an email when Daniel Schneeberger files a new 13F report
Free, no account needed. Unsubscribe with one click.
Daniel Schneeberger's portfolio
As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026
| Company | Share of portfolio | Average buy price | Return | Current price | Last quarter |
|---|---|---|---|---|---|
Abivax Sa-AdrABVX | 11.3% | $41.47 | +115% | $89.05 | Added +29% |
| 5.54% | $32.09 | +336% | $139.91 | Reduced −3.3% | |
| 5.25% | $11.61 | +195% | $34.21 | Reduced −3.9% | |
| 4.53% | $669.81 | +15.5% | $773.93 | Added +70% | |
Immunovant Inc.IMVT | 4.22% | $19.79 | +52.9% | $30.26 | Reduced −13% |
Zai Lab Ltd-AdrZLAB | 3.01% | $21.10 | +17.6% | $24.81 | Added +136% |
| 2.25% | $30.11 | +6.0% | $31.92 | Added +816% | |
Crinetics Pharmaceuticals In22663K107 | 2.15% | $38.17 | — | — | Added +7.3% |
| 1.86% | $106.11 | +11.7% | $118.48 | No change | |
| 1.83% | $57.45 | +7.9% | $62.01 | Reduced −28% | |
Septerna Inc.SEPN | 1.48% | $8.10 | +355% | $36.90 | Reduced −14% |
| 1.46% | $5.43 | +22.0% | $6.63 | Reduced −17% | |
| 1.35% | $2.92 | −2.8% | $2.84 | New | |
| 1.24% | $19.80 | −5.7% | $18.67 | Reduced −45% | |
| 1.19% | $35.66 | +124% | $79.90 | Reduced −16% | |
| 1.18% | $7.97 | +39.6% | $11.12 | Reduced −10% | |
| 1.17% | $316.12 | −16.6% | $263.55 | Added +4850% | |
Insmed Inc.INSM | 1.15% | $126.15 | −20.3% | $100.48 | Added +546% |
| 1.08% | $27.63 | +6.0% | $29.30 | Added +45% | |
| 1.05% | $32.11 | −13.6% | $27.73 | Added +152% | |
| 0.97% | $2.55 | +73.8% | $4.43 | Added +2.0% | |
| 0.95% | $52.39 | +60.3% | $83.98 | Reduced −18% | |
| 0.94% | $1.95 | +19.9% | $2.34 | Added +63% | |
| 0.92% | $29.32 | +38.6% | $40.63 | Added +18% | |
| 0.92% | $13.42 | −9.8% | $12.10 | Added +2518% | |
| 0.80% | $54.95 | −25.8% | $40.80 | Added +51% | |
| 0.79% | $71.04 | −6.1% | $66.69 | Reduced −7.5% | |
| 0.77% | $48.72 | +286% | $188.12 | Reduced −35% | |
| 0.75% | $53.03 | +14.3% | $60.61 | Reduced −13% | |
| 0.72% | $7.63 | +12.8% | $8.61 | Reduced −1.7% | |
| 0.71% | $88.47 | +1.3% | $89.64 | Reduced −36% | |
| 0.70% | $2.13 | −10.2% | $1.91 | Added +12% | |
Uniqure NVQURE | 0.70% | $45.45 | −50.4% | $22.54 | Added +326% |
Rallybio Corp.RLYB | 0.70% | $12.73 | +33.5% | $16.99 | Added +4411% |
| 0.65% | $639.14 | +15.7% | $739.57 | Added +83% | |
| 0.64% | $4.71 | −29.5% | $3.32 | Added +66% | |
| 0.63% | $16.97 | −9.7% | $15.32 | Reduced −23% | |
| 0.62% | $41.32 | +4.8% | $43.30 | Added +3.7% | |
| 0.62% | $48.78 | +33.3% | $65.04 | Added +87% | |
| 0.62% | $20.30 | −10.3% | $18.21 | Added +179% | |
| 0.59% | $2.31 | +7.1% | $2.47 | Reduced −1.3% | |
| 0.59% | $15.13 | +26.4% | $19.13 | New | |
| 0.58% | $91.58 | −0.1% | $91.47 | No change | |
| 0.57% | $1.44 | +0.3% | $1.44 | Added +0.9% | |
| 0.55% | $11.56 | +34.2% | $15.51 | Added +763% | |
Climb Bio Inc.CLYM | 0.50% | $4.65 | +133% | $10.86 | Added +38% |
| 0.50% | $10.31 | +1.8% | $10.50 | No change | |
Zura Bio Ltd.ZURA | 0.49% | $4.31 | −4.1% | $4.13 | Added +179% |
| 0.48% | $3.05 | −24.5% | $2.30 | Reduced −8.1% | |
| 0.48% | $27.04 | −4.3% | $25.88 | Added +577% | |
| 0.47% | $37.31 | −3.1% | $36.16 | Reduced −27% | |
| 0.44% | $18.66 | +110% | $39.25 | Added +3.5% | |
| 0.44% | $20.13 | +83.7% | $36.98 | Reduced −36% | |
| 0.42% | $23.13 | +10.7% | $25.61 | New | |
| 0.42% | $4.96 | +449% | $27.20 | Reduced −51% | |
| 0.41% | $20.89 | −54.3% | $9.55 | Reduced −48% | |
Savara Inc.SVRA | 0.41% | $3.23 | +49.5% | $4.83 | Reduced −4.2% |
Vaxcyte Inc.PCVX | 0.40% | $36.99 | +75.8% | $65.02 | Reduced −44% |
CG Oncology Inc.CGON | 0.40% | $29.61 | +114% | $63.26 | Reduced −36% |
| 0.38% | $26.11 | −14.3% | $22.38 | Added +93% | |
| 0.36% | $233.60 | −4.7% | $222.69 | New | |
| 0.36% | $10.10 | +4.0% | $10.50 | New | |
| 0.36% | $16.76 | +32.5% | $22.21 | Added +459% | |
Biohaven Ltd.BHVN | 0.35% | $11.71 | +1.8% | $11.93 | Added +1020% |
| 0.35% | $3.80 | −5.8% | $3.58 | Added +1.2% | |
Freenome Inc.FRNM | 0.35% | $10.51 | +50.4% | $15.81 | Added +35% |
| 0.34% | $3.43 | +30.1% | $4.46 | Reduced −3.5% | |
| 0.34% | $5.35 | −40.0% | $3.21 | Added +6.7% | |
Damora Therapeutics Inc.36322Q206 | 0.34% | $25.90 | — | — | Added +0.4% |
| 0.34% | $5.88 | +122% | $13.04 | Reduced −59% | |
Leonabio Inc.LONA | 0.34% | $5.67 | +1.4% | $5.75 | Added +6.8% |
Korro Bio Inc.KRRO | 0.33% | $11.01 | −3.9% | $10.58 | No change |
| 0.33% | $10.43 | −1.2% | $10.30 | New | |
Inflarx NVIFRX | 0.32% | $1.83 | −16.4% | $1.53 | Added +1795% |
| 0.32% | $14.52 | +19.9% | $17.41 | New | |
| 0.30% | $21.73 | −14.9% | $18.50 | Added +41% | |
| 0.30% | $1.24 | −19.5% | $1.00 | Added +113% | |
| 0.29% | $4.01 | −13.5% | $3.47 | Added +944% | |
| 0.29% | $154.21 | +112% | $327.30 | Reduced −18% | |
| 0.29% | $3.59 | +16.4% | $4.18 | Reduced −60% | |
Pfizer Inc.PFE | 0.29% | $26.30 | +5.8% | $27.82 | Added +226% |
| 0.28% | $57.72 | −15.1% | $48.99 | No change | |
| 0.27% | $25.43 | +54.2% | $39.23 | Added +58% | |
Alector Inc.ALEC | 0.27% | $1.93 | +4.6% | $2.02 | Added +175% |
| 0.27% | $4.12 | −9.1% | $3.75 | Added +1099% | |
| 0.27% | $30.63 | +98.3% | $60.74 | Reduced −0.7% | |
| 0.26% | $2.01 | +4.7% | $2.10 | Reduced −2.1% | |
| 0.26% | $10.08 | +8.2% | $10.91 | No change | |
| 0.26% | $82.39 | −11.0% | $73.33 | Added +249% | |
| 0.25% | $5.36 | +92.6% | $10.32 | Added +0.5% | |
| 0.24% | $10.04 | — | — | New | |
| 0.24% | $9.97 | +1.8% | $10.15 | No change | |
Bridgebio Pharma Inc.Bond10806XAJ1 | 0.23% | — | — | — | No change |
Bridgebio Pharma Inc.Bond10806XAD4 | 0.23% | — | — | — | No change |
| 0.23% | $218.64 | −0.5% | $217.46 | Reduced −16% | |
| 0.23% | $2.50 | +3.2% | $2.58 | New | |
| 0.23% | $28.86 | −10.9% | $25.72 | New | |
| 0.23% | $9.82 | −53.6% | $4.56 | Reduced −56% | |
Ataibeckley Inc.04650F101 | 0.23% | $3.54 | — | — | No change |
| 0.23% | $4.06 | −4.4% | $3.88 | Added +489% | |
| 0.22% | $10.63 | −0.7% | $10.56 | New | |
| 0.22% | $1.21 | −36.4% | $0.769 | New | |
Pepgen Inc.PEPG | 0.22% | $1.74 | +37.1% | $2.38 | Added +61% |
| 0.21% | $11.74 | +12.3% | $13.18 | Added +0.8% | |
Isoray Inc.CATX | 0.19% | $3.95 | −31.3% | $2.71 | Added +61% |
Apogee Therapeutics Inc.03770N101 | 0.19% | $132.73 | — | — | New |
| 0.19% | $18.99 | +12.0% | $21.26 | No change | |
| 0.19% | $11.24 | −53.1% | $5.27 | Added +27% | |
Biogen Inc.BIIB | 0.18% | $167.13 | +30.7% | $218.43 | Added +63% |
Xencor Inc.XNCR | 0.18% | $13.03 | +88.0% | $24.50 | Added +148% |
| 0.17% | $7.13 | +33.5% | $9.52 | Added +97% | |
| 0.17% | $82.75 | −45.0% | $45.54 | Added +16% | |
Pharvaris NVPHVS | 0.17% | $22.00 | +41.4% | $31.12 | No change |
| 0.17% | $1.73 | +2.9% | $1.78 | New | |
| 0.17% | $1.91 | −24.1% | $1.45 | Reduced −24% | |
| 0.17% | $5.55 | −52.3% | $2.65 | No change | |
Bridgebio Pharma Inc.Bond10806XAB8 | 0.16% | — | — | — | No change |
| 0.16% | $6.80 | +31.2% | $8.92 | New | |
| 0.16% | $323.69 | +8.2% | $350.13 | No change | |
Invivyd Inc.IVVD | 0.16% | $1.10 | −36.4% | $0.70 | Reduced −0.4% |
| 0.15% | $11.32 | — | — | Added +3.3% | |
| 0.15% | $3.53 | −28.9% | $2.51 | Added +351% | |
| 0.15% | $4.64 | −31.6% | $3.17 | No change | |
| 0.13% | $9.75 | +54.3% | $15.04 | No change | |
| 0.13% | $56.35 | −2.6% | $54.89 | Added +169% | |
| 0.13% | $20.77 | −17.3% | $17.17 | Added +109% | |
| 0.12% | $12.66 | −8.0% | $11.64 | Added +154% | |
| 0.12% | $1.51 | +60.3% | $2.42 | Reduced −34% | |
Sanofi-AdrSNY | 0.11% | $47.03 | −14.5% | $40.23 | Reduced −82% |
| 0.11% | $11.19 | −3.2% | $10.83 | Reduced −43% | |
| 0.11% | $14.23 | +58.6% | $22.57 | Added +54% | |
| 0.11% | $462.31 | −10.1% | $415.41 | Added +230% | |
| 0.11% | $1.88 | −42.1% | $1.09 | Added +46% | |
Omniab Inc.OABI | 0.11% | $2.08 | +124% | $4.66 | Added +34% |
| 0.10% | $26.64 | −69.9% | $8.01 | No change | |
| 0.10% | $79.08 | −34.2% | $52.00 | Reduced −11% | |
| 0.09% | $12.33 | +527% | $77.28 | No change | |
Vyne Therapeutics Inc.92941V308 | 0.09% | $0.63 | — | — | Added +177% |
| 0.09% | $803.99 | +15.7% | $930.25 | Added +108% | |
| 0.08% | $1.45 | +21.0% | $1.76 | No change | |
| 0.08% | $9.38 | +8.8% | $10.21 | Added +33% | |
| 0.08% | $31.56 | −29.2% | $22.33 | New | |
| 0.08% | $9.53 | −22.9% | $7.35 | No change | |
| 0.08% | $25.79 | +205% | $78.75 | No change | |
| 0.08% | $2.61 | −66.2% | $0.881 | Reduced −5.7% | |
| 0.07% | $10.25 | +2.1% | $10.46 | No change | |
| 0.07% | $7.84 | −66.5% | $2.63 | Added +0.7% | |
| 0.07% | $18.79 | +70.3% | $32.01 | New | |
Evommune Inc.EVMN | 0.06% | $18.78 | −65.9% | $6.41 | Reduced −43% |
| 0.06% | $3.26 | −12.7% | $2.85 | Added +579% | |
| 0.06% | $7.85 | +5.6% | $8.29 | Added +27% | |
| 0.06% | $44.57 | −5.5% | $42.14 | Reduced −6.1% | |
| 0.06% | $47.38 | −19.4% | $38.18 | Reduced −18% | |
Avantor Inc.AVTR | 0.06% | $10.87 | +41.6% | $15.39 | Added +63% |
| 0.06% | $1.55 | −14.2% | $1.33 | New | |
| 0.06% | $14.91 | −38.6% | $9.15 | Reduced −2.6% | |
Arrowhead Pharmaceuticals InBond04280AAC4 | 0.06% | — | — | — | New |
| 0.05% | $9.11 | −25.3% | $6.80 | New | |
| 0.05% | $1.34 | −59.4% | $0.544 | Added +3.2% | |
| 0.05% | $1.79 | −34.1% | $1.18 | New | |
| 0.05% | $57.86 | −21.2% | $45.60 | No change | |
| 0.05% | $7.41 | −7.9% | $6.82 | New | |
Cyclerion Therapeutics Inc.23255M204 | 0.05% | $3.39 | — | — | New |
Electronic Arts Inc.285512109 | 0.05% | $201.70 | — | — | No change |
Travere Therapeutics Inc.Bond89422GAB3 | 0.05% | — | — | — | New |
Biontech Se-AdrBNTX | 0.05% | $106.19 | −13.3% | $92.06 | Added +6.0% |
| 0.05% | $22.00 | −11.0% | $19.58 | New | |
| 0.04% | $14.20 | +15.3% | $16.37 | Reduced −9.8% | |
| 0.04% | $17.89 | −48.8% | $9.15 | Reduced −93% | |
| 0.04% | $44.24 | −42.0% | $25.67 | New | |
Wave Life Sciences Ltd.Y95308105 | 0.04% | $6.21 | — | — | Added +256% |
| 0.04% | $7.15 | −9.1% | $6.51 | New | |
| 0.04% | $10.58 | +4.4% | $11.04 | New | |
| 0.04% | $12.18 | −27.6% | $8.82 | New | |
Nuvalent Inc.670703107 | 0.04% | $76.68 | — | — | No change |
| 0.04% | $3.65 | −26.0% | $2.70 | Added +417% | |
| 0.04% | $36.27 | −18.0% | $29.73 | Added +14% | |
| 0.04% | $1.18 | — | — | No change | |
| 0.04% | $14.05 | −41.2% | $8.26 | No change | |
| 0.04% | $2.28 | −11.8% | $2.01 | Added +64% | |
| 0.04% | $24.19 | +49.1% | $36.06 | No change | |
Si-Bone Inc.SIBN | 0.03% | $14.67 | +28.6% | $18.86 | Added +258% |
| 0.03% | $48.75 | +15.3% | $56.21 | Added +150% | |
Evolus Inc.EOLS | 0.03% | $6.00 | +29.9% | $7.80 | Added +79% |
Ibio Inc.IBIO | 0.03% | $1.46 | −37.0% | $0.92 | Reduced −20% |
| 0.03% | $23.71 | −31.2% | $16.32 | Reduced −38% | |
Geron Corp.GERN | 0.03% | $2.11 | −42.1% | $1.22 | Added +153% |
| 0.03% | $315.13 | −12.1% | $276.97 | New | |
| 0.03% | $3.80 | +250% | $13.31 | New | |
Macrogenics Inc.MGNX | 0.03% | $3.27 | +8.4% | $3.55 | Added +225% |
| 0.03% | $121.53 | +21.0% | $147.10 | Reduced −27% | |
Natera Inc.NTRA | 0.03% | $208.59 | +87.3% | $390.79 | No change |
| 0.03% | $17.59 | +1.8% | $17.91 | New | |
| 0.03% | $22.54 | +1.3% | $22.82 | Added +2.5% | |
Cybin Inc.23256X407 | 0.03% | $7.09 | — | — | Added +160% |
| 0.03% | $11.74 | −25.5% | $8.75 | Added +129% | |
Polypid Ltd.PYPD | 0.02% | $3.71 | +31.9% | $4.90 | No change |
Pulmonx Corp.LUNG | 0.02% | $2.87 | −36.9% | $1.81 | Added +8.0% |
| 0.02% | $16.56 | −36.1% | $10.58 | Reduced −94% | |
| 0.02% | $10.16 | +4.0% | $10.57 | No change | |
| 0.02% | $1.20 | −60.0% | $0.48 | Added +288% | |
| 0.02% | $50.37 | +0.1% | $50.43 | No change | |
| 0.02% | $18.37 | +23.8% | $22.75 | Added +12% | |
| 0.02% | $363.50 | +31.2% | $476.91 | No change | |
Arvinas Inc.ARVN | 0.02% | $7.02 | +7.0% | $7.51 | No change |
| 0.02% | $17.48 | +24.5% | $21.76 | Added +26% | |
| 0.02% | $34.99 | −14.0% | $30.08 | New | |
| 0.02% | $11.48 | −37.9% | $7.13 | No change | |
| 0.02% | $94.07 | −13.5% | $81.35 | Reduced −37% | |
| 0.02% | $4.54 | −44.3% | $2.53 | No change | |
| 0.02% | $7.26 | +44.9% | $10.52 | No change | |
| 0.02% | $1.01 | −70.4% | $0.299 | Added +114% | |
| 0.02% | $103.14 | −2.9% | $100.17 | New | |
| 0.02% | $6.39 | −60.9% | $2.50 | No change | |
| 0.02% | $9.29 | +85.8% | $17.26 | No change | |
| 0.02% | $81.27 | +75.2% | $142.38 | No change | |
| 0.02% | $1.78 | −73.0% | $0.48 | Added +534% | |
| 0.02% | $116.24 | −11.7% | $102.60 | New | |
| 0.02% | $3.61 | +99.1% | $7.19 | Added +13% | |
| 0.02% | $131.03 | −19.3% | $105.70 | No change | |
| 0.02% | $33.71 | −55.6% | $14.96 | Reduced −63% | |
| 0.02% | $4.78 | +11.9% | $5.35 | New | |
| 0.02% | $12.74 | +10.8% | $14.12 | Reduced −64% | |
| 0.02% | $89.02 | −52.8% | $42.04 | Reduced −25% | |
| 0.01% | $2.99 | −12.9% | $2.60 | New | |
Verastem Inc.VSTM | 0.01% | $6.08 | +33.3% | $8.11 | Added +6.6% |
| 0.01% | $4.09 | +14.3% | $4.68 | Added +324% | |
| 0.01% | $5.71 | +4.2% | $5.95 | New | |
| 0.01% | $10.74 | −2.5% | $10.47 | No change | |
| 0.01% | $1.45 | +2.8% | $1.49 | Reduced −13% | |
| 0.01% | $3.90 | −74.8% | $0.983 | Reduced −12% | |
| 0.01% | $32.56 | −17.3% | $26.91 | No change | |
Rezolute Inc.RZLT | 0.01% | $3.29 | +41.1% | $4.64 | Reduced −17% |
Anaptysbio Inc.ANAB | 0.01% | $53.80 | −14.1% | $46.21 | No change |
Neurogene Inc.NGNE | 0.01% | $27.53 | −3.7% | $26.50 | New |
| 0.01% | $50.77 | +0.7% | $51.10 | New | |
Rxsight Inc.RXST | 0.01% | $8.75 | −44.6% | $4.85 | Added +16% |
| 0.01% | $4.68 | +6.7% | $4.99 | No change | |
| 0.01% | $5.71 | −33.3% | $3.81 | Reduced −29% | |
| 0.01% | $10.13 | +1.5% | $10.28 | No change | |
Scynexis Inc.SCYX | 0.01% | $6.21 | −32.0% | $4.22 | New |
Personalis Inc.PSNL | 0.01% | $8.44 | +90.2% | $16.06 | Reduced −40% |
| 0.01% | $4.06 | — | — | No change | |
| 0.01% | $3.29 | −40.7% | $1.95 | New | |
| 0.01% | $5.51 | −28.3% | $3.95 | Added +17% | |
| 0.01% | $10.33 | +33.1% | $13.75 | No change | |
| 0.01% | $2.15 | −66.9% | $0.712 | No change | |
| 0.01% | $3.88 | −13.7% | $3.35 | No change | |
Neuronetics Inc.STIM | 0.01% | $1.58 | +35.0% | $2.14 | No change |
| 0.01% | $2.65 | −47.6% | $1.39 | No change | |
| 0.01% | $6.52 | −63.6% | $2.37 | No change | |
| 0.01% | $11.46 | −51.7% | $5.53 | Reduced −49% | |
Veru Inc.VERU | 0.01% | $2.98 | −18.7% | $2.42 | No change |
| 0.00% | $10.09 | −0.6% | $10.03 | New | |
Clene Inc.CLNN | 0.00% | $6.23 | −37.7% | $3.88 | New |
| 0.00% | $1.00 | −75.1% | $0.25 | Reduced −53% | |
Longeveron Inc.54303L203 | 0.00% | $1.04 | — | — | Reduced −46% |
| 0.00% | $1.40 | −2.2% | $1.37 | No change | |
| 0.00% | $4.12 | −70.4% | $1.22 | No change | |
| 0.00% | $2.01 | −72.1% | $0.56 | No change | |
Ardelyx Inc.ARDX | 0.00% | $6.62 | −50.6% | $3.27 | Reduced −54% |
| 0.00% | $0.7655 | — | — | Reduced −26% | |
Atyr Pharma Inc.ATYR | 0.00% | $0.7214 | −64.7% | $0.255 | No change |
| 0.00% | $0.1386 | −45.8% | $0.0751 | No change | |
| 0.00% | $2.65 | −40.8% | $1.57 | No change | |
| 0.00% | $0.1656 | −39.6% | $0.10 | New | |
| 0.00% | $0.8638 | +23.9% | $1.07 | No change |
Daniel Schneeberger's options
As of Q2 2026. Value = shares the options cover.
| Company | Type | Value of shares covered | Last quarter |
|---|---|---|---|
| Put · bet on a fall or hedge | $18.8M | Added +127% | |
| Put · bet on a fall or hedge | $18.7M | New | |
| Put · bet on a fall or hedge | $10.7M | Added +349% | |
Abivax Sa-AdrABVX | Call · bet on a rise | $5.9M | Added +0.9% |
| Call · bet on a rise | $930K | No change | |
| Put · bet on a fall or hedge | $720.2K | New | |
| Call · bet on a rise | $667.8K | No change | |
| Call · bet on a rise | $623.2K | No change | |
| Call · bet on a rise | $562.8K | Added +71% | |
| Call · bet on a rise | $125.4K | No change | |
Cortexyme Inc.22053A107 | Put · bet on a fall or hedge | — | Sold out |
| Call · bet on a rise | — | Sold out | |
| Call · bet on a rise | — | Sold out | |
Liquidia Corp.LQDA | Put · bet on a fall or hedge | — | Sold out |
| Call · bet on a rise | — | Sold out | |
| Call · bet on a rise | — | Sold out | |
Terns Pharmaceuticals Inc.880881107 | Call · bet on a rise | — | Sold out |
Uniqure NVQURE | Call · bet on a rise | — | Sold out |
Daniel Schneeberger's buys and sells
| Company | Action | Shares change | Value now |
|---|---|---|---|
Abivax Sa-AdrABVX | Reduced −56% | −1,720,514 | $114.7M |
| Added +72% | +1,406,704 | $50.6M | |
Immunovant Inc.IMVT | Added +319% | +1,706,687 | $36.1M |
89bio Inc.282559103 | Added +141% | +1,237,170 | $31.1M |
| Added +141% | +32,000 | $36.4M | |
| Added +4.3% | +41,113 | $65.7M | |
Septerna Inc.SEPN | Added +39% | +329,264 | $22.1M |
Uniqure NVCallQURE | New | +200,000 | $11.7M |
| Added +956% | +1,386,844 | $10.2M | |
| Reduced −11% | −63,226 | $28.5M | |
Crinetics Pharmaceuticals In22663K107 | Added +368% | +195,243 | $10.3M |
Invivyd Inc.IVVD | New | +7,370,987 | $8.1M |
Metsera Inc59267L107 | New | +152,521 | $8M |
| New | +5,559,988 | $8M | |
Uniqure NVQURE | New | +133,316 | $7.8M |
| Added +465% | +288,944 | $8.6M | |
| Added +367% | +12,339 | $8.8M | |
| Added +29% | +29,025 | $10.6M | |
Ascendis Pharma A/S04351P101 | Added +2492% | +34,943 | $7.2M |
| Reduced −35% | −275,446 | $13.1M | |
Sage Therapeutics Inc.78667J108 | Sold out | −721,599 | — |
| Reduced −56% | −1,905,911 | $14.3M | |
Janux Therapeutics Inc.CallJANX | Sold out | −264,900 | — |
| Added +31% | +964,000 | $12.9M | |
| New | +501,228 | $5.8M | |
| Added +12% | +5,000 | $30.3M | |
Verve Therapeutics Inc.92539P101 | Sold out | −469,018 | — |
Ataibeckley Inc.N0731H103 | New | +913,242 | $4.8M |
| Sold out | −442,615 | — | |
| New | +11,200 | $4.7M | |
Vaxcyte Inc.PCVX | Added +117% | +115,032 | $7.7M |
| Added +2.7% | +77,453 | $13.2M | |
| Sold out | −53,337 | — | |
Aa Mission Acquisition Cor-ACallAAM | New | +405,089 | $4.3M |
| Reduced −28% | −338,899 | $11.8M | |
| New | +40,000 | $4M | |
| Added +9312% | +968,494 | $4.1M | |
| Added +356% | +56,211 | $4.1M | |
Ardelyx Inc.ARDX | Sold out | −915,130 | — |
CG Oncology Inc.CGON | Reduced −52% | −274,299 | $10M |
Third Harmonic Bio Inc.88427A107 | Sold out | −622,873 | — |
| New | +18,523 | $3.3M | |
Rezolute Inc.RZLT | Reduced −18% | −173,322 | $7.7M |
| Added +66% | +139,494 | $6.7M | |
Bioage Labs Inc.BIOA | Reduced −2.9% | −57,050 | $11.1M |
Sanofi-AdrSNY | Added +642% | +64,212 | $3.5M |
| Added +5.3% | +13,755 | $14.2M | |
| Reduced −9.9% | −14,643 | $8.8M | |
| Added +159% | +108,106 | $4.6M | |
| Added +81% | +23,000 | $5.5M | |
| Added +540% | +288,263 | $3.1M | |
| New | +7,000 | $2.7M | |
| Added +263% | +65,688 | $3.7M | |
Centessa Pharmaceuticals-Adr152309100 | Reduced −82% | −243,100 | $1.3M |
Alector Inc.ALEC | Sold out | −1,723,526 | — |
Avidity Biosciences Inc.05370A108 | New | +53,656 | $2.3M |
| Reduced −5.8% | −174,190 | $9.3M | |
Masimo Corp.574795100 | New | +15,000 | $2.2M |
Merus NVN5749R100 | Added +82% | +15,000 | $3.1M |
Cormedix Inc.CRMD | Sold out | −175,000 | — |
| Added +9.2% | +4,181 | $5M | |
Summit Therapeutics Inc.CallSMMT | Sold out | −100,000 | — |
| Added +364% | +3,841 | $2.2M | |
Blueprint Medicines Corp.09627Y109 | Sold out | −15,000 | — |
Biogen Inc.BIIB | Added +253% | +12,900 | $2.5M |
| Added +758% | +90,969 | $2.1M | |
Zura Bio Ltd.ZURA | Reduced −35% | −345,393 | $2.8M |
Arcellx Inc.03940C100 | Added +125% | +17,522 | $2.6M |
| Added +90% | +51,976 | $2.8M | |
| New | +215,752 | $1.6M | |
| Added +3.7% | +5,000 | $6.5M | |
| New | +150,000 | $1.5M | |
| Added +2.5% | +125,498 | $8.5M | |
Akero Therapeutics Inc.00973Y108 | Reduced −81% | −27,000 | $291.7K |
| New | +52,450 | $1.4M | |
| Added +33% | +18,647 | $2.9M | |
| Sold out | −250,000 | — | |
| Added +1.8% | +2,000 | $3.3M | |
| Added +109% | +300,000 | $1.9M | |
| Reduced −85% | −121,940 | $400.8K | |
Omniab Inc.OABI | Added +234% | +764,520 | $1.7M |
Springworks Therapeutics Inc.85205L107 | Sold out | −24,082 | — |
| Reduced −63% | −333,900 | $889.3K | |
| Reduced −74% | −223,887 | $3M | |
Savara Inc.SVRA | Reduced −45% | −1,612,382 | $7.1M |
Korro Bio Inc.KRRO | Reduced −42% | −28,580 | $1.9M |
Cortexyme Inc.22053A107 | Added +442% | +632,076 | $1.3M |
| Added +163% | +11,500 | $1.6M | |
Electronic Arts Inc.285512109 | New | +4,936 | $995.6K |
Biontech Se-AdrBNTX | New | +10,000 | $986.2K |
Argenx SE - ADRARGX | Sold out | −1,759 | — |
| Sold out | −249,920 | — | |
Sarepta Therapeutics Inc.CallSRPT | Sold out | −55,000 | — |
Nektar TherapeuticsPutNKTR | Sold out | −35,000 | — |
Keen Vision Acquisition Corp.CallKVACF | New | +75,000 | $863.3K |
| Sold out | −75,000 | — | |
| Reduced −9.8% | −5,400 | $1.7M | |
Xencor Inc.XNCR | Added +50% | +43,039 | $1.5M |
Urogen Pharma Ltd.CallURGN | New | +40,000 | $798K |
Apogee Therapeutics Inc.03770N101 | Sold out | −18,070 | — |
| New | +373,682 | $710K | |
| New | +292,397 | $707.6K | |
Fulcrum Therapeutics Inc.CallFULC | New | +75,000 | $690K |
| New | +14,418 | $689K | |
Dayforce Inc.15677J108 | New | +10,000 | $688.9K |
| New | +26,045 | $675.3K | |
| Reduced −49% | −19,590 | $748K | |
| New | +3,578 | $639.5K | |
| New | +59,230 | $595.3K | |
| Sold out | −13,366 | — | |
| Reduced −24% | −17,498 | $878.8K | |
| Added +250% | +25,000 | $698.3K | |
| New | +50,000 | $546.5K | |
| New | +20,000 | $544.2K | |
| New | +11,619 | $541.2K | |
| Added +341% | +117,181 | $1.1M | |
| New | +10,000 | $530.8K | |
| Reduced −27% | −70,405 | $7.6M | |
| Added +98% | +173,823 | $1M | |
| New | +50,000 | $508.5K | |
Kala Bio Inc.483119202 | Reduced −5.2% | −7,835 | $217.3K |
| Reduced −66% | −102,129 | $406.6K | |
| New | +18,947 | $485K | |
| Reduced −2.7% | −25,000 | $1.5M | |
| Reduced −50% | −20,000 | $432.8K | |
| New | +6,000 | $445.2K | |
Nabors Energy Transition CorG6363K106 | Sold out | −39,900 | — |
| Reduced −73% | −307,703 | $401.4K | |
Novocure Ltd.NVCR | New | +34,000 | $439.3K |
GBS Inc.36151G600 | New | +426,433 | $435K |
Natera Inc.NTRA | Sold out | −2,500 | — |
Alkermes PLCALKS | Added +25% | +11,200 | $1.7M |
Novocure Ltd.CallNVCR | New | +30,000 | $387.6K |
| Reduced −23% | −78,062 | $5.4M | |
| Added +50% | +75,000 | $2.4M | |
| New | +6,000 | $374.9K | |
| Added +100% | +500 | $763K | |
Polypid Ltd.PYPD | Sold out | −103,950 | — |
| New | +36,200 | $354.4K | |
| New | +10,000 | $349.8K | |
Bridgebio Pharma Inc.Bond10806XAB8 | Reduced −99% | −1,980,000 | $2.8M |
| Sold out | −27,285 | — | |
Inmune Bio Inc.PutINMB | Sold out | −130,200 | — |
Zai Lab Ltd-AdrZLAB | Added +2.2% | +18,343 | $29.4M |
| Added +3.1% | +1,100 | $1.5M | |
| Added +60% | +20,700 | $486.8K | |
| New | +10,245 | $282.4K | |
| Reduced −6.5% | −14,697 | $559K | |
Regenxbio Inc.RGNX | Reduced −1.2% | −2,409 | $2M |
| New | +9,000 | $270.7K | |
Iteos Therapeutics Inc.46565G104 | Sold out | −26,937 | — |
| Sold out | −25,000 | — | |
Bridgebio Pharma Inc.Bond10806XAD4 | Reduced −99% | −4,455,000 | $4.4M |
| Added +63% | +14,600 | $476.4K | |
| Reduced −53% | −88,838 | $916K | |
Soleno Therapeutics Inc.834203309 | Added +46% | +7,900 | $1.7M |
| Added +44% | +15,800 | $748K | |
Olema Pharmaceuticals Inc.CallOLMA | New | +25,000 | $244.8K |
Arvinas Inc.ARVN | Reduced −36% | −46,176 | $703.7K |
| New | +81,000 | $235.7K | |
| Reduced −71% | −87,467 | $153.2K | |
Inflarx NVIFRX | New | +159,479 | $213.7K |
Replimune Group Inc.CallREPL | New | +50,000 | $209.5K |
| Reduced −20% | −28,378 | $217.2K | |
Cybin Inc.23256X407 | New | +33,278 | $196K |
| Reduced −40% | −68,894 | $2.2M | |
Kezar Life Sciences Inc.49372L209 | Reduced −15% | −22,437 | $487.4K |
Pulmonx Corp.LUNG | Added +4.9% | +10,000 | $347.5K |
Avantor Inc.AVTR | Added +150% | +15,000 | $312K |
Pfizer Inc.PFE | Added +13% | +5,000 | $1.1M |
| Added +152% | +16,260 | $282.9K | |
| Sold out | −30,000 | — | |
| New | +25,000 | $163.5K | |
Apellis Pharmaceuticals03753U106 | Added +18% | +3,000 | $452.6K |
Colombier Acquisition Corp. IG2283U100 | Sold out | −10,000 | — |
| Sold out | −16,221 | — | |
Inozyme Pharma Inc.45790W108 | Sold out | −37,161 | — |
Pepgen Inc.PEPG | Added +81% | +16,490 | $170.2K |
| New | +16,712 | $145.2K | |
Gossamer Bio Inc.CallGOSS | New | +55,100 | $144.9K |
| Sold out | −42,408 | — | |
Generation Bio Co.37148K209 | New | +22,144 | $135.5K |
Alumis Inc.ALMS | Added +62% | +23,503 | $244.6K |
| New | +10,200 | $129K | |
Atyr Pharma Inc.ATYR | New | +175,000 | $126.2K |
Wave Life Sciences Ltd.Y95308105 | Added +3.7% | +4,253 | $871.6K |
Moonlake ImmunotherapeuticsCallMLTX | New | +17,000 | $121.9K |
Climb Bio Inc.CLYM | Added +12% | +14,210 | $268.4K |
| Added +1.3% | +200 | $425.6K | |
| Reduced −69% | −72,337 | $411.7K | |
| Added +100% | +25,000 | $175K | |
Iovance Biotherapeutics Inc.CallIOVA | New | +50,000 | $108.5K |
Ventyx Biosciences Inc.92332V107 | Reduced −52% | −87,000 | $253.8K |
| Reduced −32% | −20,524 | $504.9K | |
Engene Holdings Inc.29286M105 | Sold out | −27,787 | — |
| Sold out | −82,189 | — | |
Biomx Inc09090D301 | Reduced −74% | −221,942 | $40.8K |
| Sold out | −10,000 | — | |
Atyr Pharma Inc.PutATYR | Added +345% | +172,500 | $160.5K |
Biohaven Ltd.BHVN | Reduced −25% | −8,000 | $365.4K |
Neurogene Inc.NGNE | Added +3.4% | +1,008 | $530.9K |
| Reduced −56% | −44,945 | $163.5K | |
Essa Pharma Inc.29668H708 | Sold out | −50,000 | — |
| Sold out | −10,000 | — | |
| Sold out | −102,948 | — | |
| Sold out | −130,000 | — | |
| Reduced −0.8% | −1,916 | $761.3K | |
Astria Therapeutics Inc.04635X102 | Reduced −22% | −55,712 | $1.4M |
Bioatla Inc.09077B104 | Sold out | −170,506 | — |
Solidion Technology Inc.CallSTI | New | +13,500 | $62.6K |
| Sold out | −10,823 | — | |
Atyr Pharma Inc.CallATYR | New | +84,800 | $61.2K |
Nextcure Inc.65343E108 | Sold out | −118,012 | — |
| Added +11% | +4,627 | $150.6K | |
| Sold out | −44,120 | — | |
Aa Mission Acquisition Cor-AG1000R127 | Sold out | −505,099 | — |
| Sold out | −16,900 | — | |
| Reduced −9.1% | −250 | $329.5K | |
Terns Pharmaceuticals Inc.880881107 | Reduced −65% | −18,415 | $75.1K |
| New | +15,000 | $30.2K | |
Renovorx Inc.RNXT | Sold out | −19,889 | — |
| Sold out | −10,000 | — | |
| Reduced −89% | −103,021 | $16.7K | |
Jvspac Acquisition Corp.G5212E113 | Sold out | −24,000 | — |
| New | +13,097 | $20.8K | |
Ibio Inc.IBIO | Reduced −51% | −27,819 | $22.4K |
| Added +0.5% | +830 | $466.9K | |
Movano Inc.62459M206 | Sold out | −19,146 | — |
Connect Biopharma Holdings Ltd.207523101 | Sold out | −10,300 | — |
CN Healthy Food Tech Group C462837121 | Sold out | −12,320 | — |
| Sold out | −75,000 | — | |
| Reduced −40% | −9,170 | $216.4K | |
Geron Corp.GERN | Added +3.4% | +15,000 | $625K |
| Sold out | −13,144 | — | |
| Sold out | −18,000 | — | |
| Reduced −35% | −14,095 | $11.7K |
Daniel Schneeberger's portfolio by sector
Share of the stock portfolio at Q2 2026.
| Sector | Share |
|---|---|
| Health Care | 87% |
| Other | 11% |
| Financials | 2.1% |
| Technology | 0.3% |
| Industrials | 0.2% |
| Real Estate | 0.1% |
| Consumer Discretionary | 0.0% |
Portfolio performance: Daniel Schneeberger vs. benchmarks
Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.
- You, copying after each 13F filing – estimated value
- S&P 500
- Nasdaq-100
| Total return | Per year | |
|---|---|---|
| You, copying after each 13F filing – estimated value | +98.6% | +29.6% |
| S&P 500 | +60.3% | +19.5% |
| Nasdaq-100 | +75.1% | +23.6% |
Prices were available for 87% of the portfolio value on average; the rest is left out of the return.
Daniel Schneeberger's most traded stocks
Quarters with a buy or a sell, all reports since Q4 2023.
| Company | Quarters bought | Quarters sold |
|---|---|---|
| 8 | 4 | |
| 6 | 4 | |
| 6 | 4 | |
| 7 | 3 | |
Vaxcyte Inc.PCVX | 6 | 4 |
Regenxbio Inc.RGNX | 4 | 6 |
Abivax Sa-AdrABVX | 8 | 2 |
Alkermes PLCALKS | 5 | 5 |
| 8 | 2 | |
Biohaven Ltd.BHVN | 7 | 3 |
Sanofi-AdrSNY | 6 | 4 |
| 5 | 5 | |
Pfizer Inc.PFE | 6 | 4 |
| 5 | 5 | |
Savara Inc.SVRA | 7 | 3 |